Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial
- PMID: 29599185
- DOI: 10.1183/13993003.00354-2018
Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial
Conflict of interest statement
Conflict of interest: P. González-Ponce is an employee of Linde Healthcare. Conflict of interest: M.I. Ramos is an employee of Linde Healthcare. Conflict of interest: J.I. Conforto is an employee of Linde Healthcare. Conflict of interest: S. Jafri is an employee of The Linde Group.
Comment in
-
Making sense of telemedicine in the management of COPD.Eur Respir J. 2018 May 30;51(5):1800851. doi: 10.1183/13993003.00851-2018. Print 2018 May. Eur Respir J. 2018. PMID: 29848578 No abstract available.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical